Intec's Accordion Pill™ is ideal for oral delivery of a wide range of molecules characterized by a narrow absorption window. In addition, Accordion Pill™ products significantly improve patient compliance by reducing dose frequency.

Intec's Accordion Pill™ offers an excellent delivery method for targeted drug therapy to the gastrointestinal lining. This represents a significant advantage over current systemic methods for treatment of various gastrointestinal diseases such as local infectious diseases, as well as various GI disorders.

Accordion Pill™ products also open opportunities for chronopharmacological (targeted time release) applications. The Accordion Pill™ platform has proven effective with water soluble and poorly-soluble molecules with different physiochemical characteristics and molecular-sizes. These include small molecular weight pharmaceutics as well as peptide-based drugs. Human studies have demonstrated therapeutic drug delivery, excellent bioavailability, and clear advantages in comparison to existing delivery methods.

Intec has conducted 12 human clinical trials on more than 350 healthy volunteers, demonstrating the ability of Intec's Accordion Pill™ products to produce the desired gastric-retention and efficient delivery of various types of drug molecules with different physiochemical characteristics.